Pulmonx Corp
(STU:4NI)
€
6.8
0.05 (0.74%)
Market Cap: 272.17 Mil
Enterprise Value: 224.02 Mil
PE Ratio: 0
PB Ratio: 3.09
GF Score: 59/100 Pulmonx Corp at Citi Healthcare & Medtech Conference Transcript
Mar 02, 2023 / 06:15PM GMT
Release Date Price:
€10.7
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
So the music has died down, which tells me, it's time for us to start the next presentation. I am still Joanne Wuensch from Citibank. And this time, we have with us the management team from Pulmonx. So welcome to New York City.
Glendon E. French
Pulmonx Corporation - CEO, President & Director
Thank you for having us.
Questions & Answers
Joanne Karen Wuensch;Glendon E. French
Citigroup Inc., Research Division - MD;Pulmonx Corporation - CEO, President &
It's interesting as I try to follow or I do follow the Zephyr Valve launch and uptake. And we've spent a fair amount of time talking about the eases or obstacles to product adoption, particularly launching a new product during the pandemic. So I'd like to sort of start our conversation today from a big picture vantage point. Where are we in terms of the product launch? And where are you maybe in terms of moving some of those obstacles out of the way.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot